STOCK TITAN

Director at Walker & Dunlop (WD) receives 3,096 restricted shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hayward Jeffery R reported acquisition or exercise transactions in this Form 4 filing.

Walker & Dunlop, Inc. director Jeffery R. Hayward received a grant of 3,096 shares of common stock at no cost as equity compensation. The award was made under the Walker & Dunlop, Inc. 2024 Equity Incentive Plan and consists of restricted common stock that vests on the one-year anniversary of the grant date. Following this grant, Hayward directly holds 6,712 shares of Walker & Dunlop common stock.

Positive

  • None.

Negative

  • None.
Insider Hayward Jeffery R
Role null
Type Security Shares Price Value
Grant/Award Common Stock 3,096 $0.00 --
Holdings After Transaction: Common Stock — 6,712 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Equity grant size 3,096 shares Restricted common stock awarded to director on grant date
Grant price per share $0.00 per share Stated transaction price for the restricted stock award
Post-grant holdings 6,712 shares Total common shares directly owned after the grant
Vesting schedule One-year cliff vesting Restricted shares vest on one-year anniversary of grant date
restricted common stock financial
"The shares of restricted common stock vest on the one-year anniversary of the grant date."
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
2024 Equity Incentive Plan financial
"subject to the terms of the Walker & Dunlop, Inc. 2024 Equity Incentive Plan."
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hayward Jeffery R

(Last)(First)(Middle)
C/O WALKER & DUNLOP, INC.
7272 WISCONSIN AVENUE, SUITE 1300

(Street)
BETHESDA MARYLAND 20814

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Walker & Dunlop, Inc. [ WD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/19/2026A3,096(1)A$06,712D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock granted to the reporting person, which are subject to the terms of the Walker & Dunlop, Inc. 2024 Equity Incentive Plan. The shares of restricted common stock vest on the one-year anniversary of the grant date.
/s/ Nicholas C. Eckstein, Attorney-in-fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Walker & Dunlop (WD) director Jeffery R. Hayward report on this Form 4?

Director Jeffery R. Hayward reported receiving 3,096 shares of Walker & Dunlop common stock as an equity grant. The shares were awarded at no cost and are part of his director compensation, increasing his direct holdings to 6,712 shares after the transaction.

Is the Jeffery R. Hayward Form 4 transaction in WD stock a purchase or a grant?

The transaction is a grant, not an open-market purchase. Hayward received 3,096 shares of Walker & Dunlop common stock at a stated price of $0.00 per share as compensation, under the company’s 2024 Equity Incentive Plan, rather than buying shares in the market.

How many Walker & Dunlop (WD) shares does Jeffery R. Hayward hold after this grant?

After the equity award, Jeffery R. Hayward directly owns 6,712 shares of Walker & Dunlop common stock. This total includes the newly granted 3,096 restricted shares reported in the Form 4, which were added to his previously held position as a company director.

What are the vesting terms of the 3,096 WD shares granted to Jeffery R. Hayward?

The 3,096 Walker & Dunlop shares are restricted common stock that vest on the one-year anniversary of the grant date. Until vesting, the award remains subject to the terms and conditions of the company’s 2024 Equity Incentive Plan governing such restricted stock grants.

Under which plan were the 3,096 Walker & Dunlop shares granted to Hayward?

The 3,096-share grant to Jeffery R. Hayward was issued under the Walker & Dunlop, Inc. 2024 Equity Incentive Plan. This plan governs equity-based compensation awards, including restricted common stock, and specifies the vesting schedule and other conditions applicable to the granted shares.